About
This group investigates the pharmacokinetics and dynamics of antimicrobial agents. Research ranges from in vitro experiments to clinical trials in special patient populations, such as critically ill, hematology and obese patients. The main aim is to define the optimal dose for each patient.Aims Our group has several aims
- To study drug behavior with the goal to improve the treatment of bacterial infections
- To explore the contribution of renal function on the exposure of antimicrobial agents